CPI-17による腫瘍性変異は,メルリンリンホスファタゼの抑制による
Hongchuan Jin1, Tobias Sperka, Peter Herrlich
1Leibniz Institute of Age Research-Fritz-Lipmann-Institute, Beutenbergstrasse 11, 07745 Jena, Germany.
Nature
|August 4, 2006
まとめ
ミオシン・フォスファターゼ (MYPT-1-PP1delta) は,デフォスフォリレーションによって腫瘍抑制物質マーリンを活性化します. その阻害剤であるCPI-17は,このマーリン経路を妨害することによって癌を促進し,新しい腫瘍抑制カスケードを強調します.
科学分野:
- 分子生物学は分子生物学である.
- 細胞生物学 細胞生物学
- 腫瘍学 腫瘍学
背景:
- メルリン (ニューロフィブロマトーシス2型遺伝子NF2) は,細胞増殖を調節する腫瘍抑制剤である.
- マーリンの活性化には,セリン518 (S518) での脱リン酸化が必要ですが,その責任を負うフォスファターゼは不明でした.
研究 の 目的:
- マーリンの腫瘍抑制機能を活性化するフォスファターゼを特定するために.
- このフォスファタゼとその阻害剤ががんにおける役割を調査する.
主な方法:
- 酵素識別アッセイ 酵素識別アッセイ
- メルリン変異体とCPI-17阻害剤を用いた細胞アッセイ.
- 人間の腫瘍細胞系におけるCPI-17レベルの分析.
主要な成果:
- ミオシン・フォスファターゼ (MYPT-1-PP1delta) は,メルリン活性化フォスファターゼとして特定されました.
- MYPT-1-PP1デルタ特異性阻害体CPI-17はメルリンリン酸化,Ras活性化,細胞変異を引き起こす.
- CPI-17のダウンレギュレーションにより,これらの腫瘍学的効果は逆転し,マーリンが主要な基質であることを確認しました.
結論:
- MYPT-1-PP1deltaとmerlinは新しい腫瘍抑制カスケードを形成しています.
- このカスケードは,NF2変異またはCPI-17レベルの増加によって破壊され,腫瘍発生に寄与する可能性があります.
関連する概念動画
Abnormal Proliferation
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Cancer-Critical Genes I: Proto-oncogenes
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
mTOR Signaling and Cancer Progression
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
Interactions Between Signaling Pathways
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
PI3K/mTOR/AKT Signaling Pathway
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a rapamycin-insensitive companion...
Induced Pluripotent Stem Cells
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic cells are...
Somatic cells are...
